{"id":"https://openalex.org/W2586974029","doi":"https://doi.org/10.1182/blood.v104.11.1680.1680","title":"Growth after Hematopoietic Cell Transplantation for Sickle Cell Disease.","display_name":"Growth after Hematopoietic Cell Transplantation for Sickle Cell Disease.","publication_year":2004,"publication_date":"2004-11-16","ids":{"openalex":"https://openalex.org/W2586974029","doi":"https://doi.org/10.1182/blood.v104.11.1680.1680","mag":"2586974029"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v104.11.1680.1680","doi":"https://doi.org/10.1182/blood.v104.11.1680.1680","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v104.11.1680.1680","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040299600","display_name":"Mark C. Walters","orcid":"https://orcid.org/0000-0002-6515-4559","observed_orcids":["https://orcid.org/0000-0002-6515-4559"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark C. Walters","raw_affiliation_strings":["Hematology/Oncology, Children\u2019s Hospital & Research Center at Oakland, Oakland, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology/Oncology, Children\u2019s Hospital & Research Center at Oakland, Oakland, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112079948","display_name":"Melinda Patience","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Melinda Patience","raw_affiliation_strings":["Hematology/Oncology, Children\u2019s Hospital & Research Center at Oakland, Oakland, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology/Oncology, Children\u2019s Hospital & Research Center at Oakland, Oakland, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103880207","display_name":"Sandie Edwards","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Sandie Edwards","raw_affiliation_strings":["Hematology/Oncology, Children\u2019s Hospital & Research Center at Oakland, Oakland, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology/Oncology, Children\u2019s Hospital & Research Center at Oakland, Oakland, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073862011","display_name":"Shanda Robertson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Shanda Robertson","raw_affiliation_strings":["Hematology/Oncology, Children\u2019s Hospital & Research Center at Oakland, Oakland, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology/Oncology, Children\u2019s Hospital & Research Center at Oakland, Oakland, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031824054","display_name":"Karen L. Kesler","orcid":"https://orcid.org/0000-0002-4425-7348","observed_orcids":["https://orcid.org/0000-0002-4425-7348"]},"institutions":[{"id":"https://openalex.org/I4210153694","display_name":"Rho (United States)","ror":"https://ror.org/049ba1e57","country_code":"US","type":"company","lineage":["https://openalex.org/I4210153694"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Karen Kesler","raw_affiliation_strings":["Rho, Inc., Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rho, Inc., Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I4210153694"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087657412","display_name":"Marsha A. McMurray","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153694","display_name":"Rho (United States)","ror":"https://ror.org/049ba1e57","country_code":"US","type":"company","lineage":["https://openalex.org/I4210153694"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Marsha McMurray","raw_affiliation_strings":["Rho, Inc., Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rho, Inc., Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I4210153694"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111664451","display_name":"Sharyne M Donfield","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153694","display_name":"Rho (United States)","ror":"https://ror.org/049ba1e57","country_code":"US","type":"company","lineage":["https://openalex.org/I4210153694"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sharyne Donfield","raw_affiliation_strings":["Rho, Inc., Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rho, Inc., Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I4210153694"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087625822","display_name":"Barry S. Eggleston","orcid":"https://orcid.org/0000-0003-0472-9707","observed_orcids":["https://orcid.org/0000-0003-0472-9707"]},"institutions":[{"id":"https://openalex.org/I4210153694","display_name":"Rho (United States)","ror":"https://ror.org/049ba1e57","country_code":"US","type":"company","lineage":["https://openalex.org/I4210153694"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Barry Eggleston","raw_affiliation_strings":["Rho, Inc., Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rho, Inc., Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I4210153694"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5031824054","https://openalex.org/A5073862011","https://openalex.org/A5087625822","https://openalex.org/A5087657412","https://openalex.org/A5103880207","https://openalex.org/A5111664451","https://openalex.org/A5112079948"],"corresponding_institution_ids":["https://openalex.org/I4210153694"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.39116074,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"104","issue":"11","first_page":"1680","last_page":"1680"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.017400000244379044,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sickle-cell-disease","display_name":"sickle cell disease","score":0.9940000176429749},{"id":"https://openalex.org/keywords/allogeneic-hematopoietic-stem-cell-transplantation","display_name":"allogeneic hematopoietic stem cell transplantation","score":0.9760000109672546},{"id":"https://openalex.org/keywords/child-growth","display_name":"child growth","score":0.5600000023841858},{"id":"https://openalex.org/keywords/linear-growth-velocity","display_name":"linear growth velocity","score":0.9440000057220459},{"id":"https://openalex.org/keywords/height-and-weight","display_name":"height and weight","score":0.7580000162124634},{"id":"https://openalex.org/keywords/hydroxyurea","display_name":"hydroxyurea","score":0.8920000195503235},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":0.6119999885559082},{"id":"https://openalex.org/keywords/children","display_name":"children","score":0.35100001096725464}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6771972179412842},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.6722123622894287},{"id":"https://openalex.org/C2993713153","wikidata":"https://www.wikidata.org/wiki/Q211709","display_name":"Hematopoietic cell","level":4,"score":0.5629725456237793},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.559022068977356},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.5197288990020752},{"id":"https://openalex.org/C2778620579","wikidata":"https://www.wikidata.org/wiki/Q185034","display_name":"Sickle cell anemia","level":3,"score":0.4997551441192627},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.48375844955444336},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3981879651546478},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.338911235332489},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.1729733645915985},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12058910727500916},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v104.11.1680.1680","doi":"https://doi.org/10.1182/blood.v104.11.1680.1680","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v104.11.1680.1680","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2171127937","https://openalex.org/W3149833113","https://openalex.org/W2020899603","https://openalex.org/W2000488109","https://openalex.org/W3096711633","https://openalex.org/W2607115608","https://openalex.org/W2330996092","https://openalex.org/W7093121636","https://openalex.org/W2938664723","https://openalex.org/W2969400921"],"abstract_inverted_index":{"Abstract":[0],"Although":[1],"allogeneic":[2],"hematopoietic":[3],"cell":[4,12],"transplantation":[5],"(HCT)":[6],"has":[7],"curative":[8],"potential":[9],"for":[10,78,218,233,240,266,291,403,440],"sickle":[11],"disease":[13],"(SCD),":[14],"the":[15,98,125,158,174,191,195,202,207,243,259,280,296,307,317,329,340,351,369,383,397,431,436],"impact":[16,450],"on":[17,361,374,451],"growth":[18,41,115,277,353,400,420],"in":[19,71,124,145,157,173,180,186,206,225,242,316,328,339,350,368,382,418,430],"children":[20,48,56,79,91,198,410],"treated":[21,199,357],"by":[22,200,358],"HCT":[23,159,308,330,341,359,402,425,439],"is":[24,405],"important":[25],"to":[26,44,215,222,230,237,253,409],"consider":[27],"when":[28],"counseling":[29],"families":[30],"about":[31],"this":[32],"therapeutic":[33,445],"intervention.":[34],"To":[35,189],"investigate":[36],"this,":[37],"we":[38],"compared":[39,408],"linear":[40,276,352],"after":[42,117,168,401,424],"BMT":[43],"3":[45,229],"cohorts":[46,212],"of":[47,76,101,107,127,139,149,155,194,261,269,337],"with":[49,57,80,92],"SCD.":[50,82],"The":[51,83,152,283],"comparison":[52,85,161,203,310],"groups":[53,162,311],"included":[54,87],"68":[55],"SCD":[58,404,441],"who":[59,411],"were":[60,143,288,299,321,346],"measured":[61],"before":[62],"enrollment":[63],"(HUG-KIDS":[64,69],"Pre)":[65],"and":[66,89,94,132,134,141,147,160,183,209,220,227,235,256,271,275,285,293,309,342,372,385],"during":[67,279],"treatment":[68],"HU)":[70],"a":[72,443,448],"phase":[73],"I-II":[74],"trial":[75],"hydroxyurea":[77],"symptomatic":[81],"third":[84],"group":[86,267,320],"1887":[88],"1889":[90],"height":[93,140,255,270,284,302],"weight":[95,142,257,272,286,304,379],"data":[96,287,395],"from":[97],"Cooperative":[99],"Study":[100],"Sickle":[102],"Cell":[103],"Disease":[104],"(CSSCD).":[105],"Fifty-three":[106],"55":[108],"surviving":[109],"patients":[110],"(20":[111],"F,":[112],"33M)":[113],"had":[114],"monitored":[116],"HCT.":[118],"There":[119],"was":[120,163,213,228,251,421],"no":[121,300,347],"significant":[122,301,444],"difference":[123],"distribution":[126,193],"repeated":[128],"measurements":[129,138],"between":[130,306],"males":[131,292,315,327,338,356,367,381,428],"females,":[133,226,313],"2":[135],"or":[136,303,415],"more":[137,365,378,422],"performed":[144],"89%":[146],"92%":[148],"patients,":[150],"respectively.":[151],"mean":[153],"period":[154,260],"follow-up":[156,281],"3.3":[164],"\u00b1":[165,177],"2.4":[166],"years":[167,172,179,185,217,224,232,239],"HCT,":[169,201],"5.5":[170],"\u00b13.3":[171],"CSSCD,":[175,384],"4.0":[176],"2.7":[178],"HUG-KIDS":[181,187,210,244,318],"(pre)":[182,245,319],"1.8\u00b10.5":[184],"(HU).":[188],"accommodate":[190],"non-identical":[192],"ages":[196],"among":[197,312,427],"age":[204],"range":[205],"CSSCD":[208,343,370],"(HU)":[211],"5":[214],"15":[216,223],"males,":[219,234,419],"6":[221],"13":[231,238],"4":[236,323],"females":[241],"cohort.":[246],"A":[247],"Hierarchical":[248],"Linear":[249],"Model":[250],"used":[252],"model":[254],"over":[258],"follow-up.":[262],"Its":[263],"design":[264],"allowed":[265],"comparisons":[268,334],"at":[273],"baseline":[274],"velocity":[278],"period.":[282],"modeled":[289],"separately":[290],"females.":[294],"At":[295],"baseline,":[297],"there":[298,345],"differences":[305,349,387],"however,":[314],"approximately":[322],"cm":[324],"taller":[325],"than":[326,366,380,426],"group.":[331],"In":[332],"all":[333],"except":[335],"that":[336,399,438],"groups,":[344],"strong":[348],"velocity.":[354],"However,":[355],"grew":[360],"average":[362,375],"0.67":[363],"cm/year":[364],"group,":[371],"gained":[373],"1.0":[376],"kg/year":[377],"these":[386],"reached":[388],"statistical":[389],"significance":[390],"(p=0.03,":[391],"p=0.002,":[392],"respectively).":[393],"These":[394],"support":[396],"conclusion":[398],"not":[406],"impaired":[407],"receive":[412],"standard":[413],"therapy":[414],"HU.":[416],"Moreover,":[417],"rapid":[423],"enrolled":[429],"CSSCD.":[432],"This":[433],"analysis":[434],"supports":[435],"notion":[437],"offers":[442],"benefit":[446],"without":[447],"negative":[449],"growth.":[452]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-02-17T00:00:00"}